Title: β3 Adrenergic Receptor Signaling in the Human Myometrium.

Area of Science:

• Pharmacology
• Reproductive Medicine
• Molecular Biology

Background:

• Preterm birth is a major cause of infant mortality.
• Existing treatments like beta2 adrenergic agonists are often inadequate.
• Beta3 adrenergic receptors in the myometrium offer a potential therapeutic target.

Purpose of the Study:

• To investigate the role of beta3 adrenergic receptors in human myometrium.
• To evaluate the tocolytic potential of the beta3 agonist mirabegron.
• To elucidate the signaling pathways involved in mirabegron-mediated myometrial relaxation.

Main Methods:

• Western blot analysis to assess beta3 adrenergic receptor expression.
• Myometrial tissue bath studies to measure relaxation responses to mirabegron.
• Pharmacological blockade of nitric oxide synthase (eNOS) and potassium channels.
• Cellular imaging and nitric oxide production assays.

Main Results:

• Beta3 adrenergic receptor expression is increased in human pregnancy myometrium.
• Mirabegron effectively relaxed oxytocin-contracted myometrium.
• Relaxation was partially mediated by eNOS and large conductance potassium channels.
• Mirabegron stimulated nitric oxide production in myometrial endothelial cells.

Conclusions:

• Beta3 adrenergic receptor signaling contributes to myometrial relaxation.
• Mirabegron's tocolytic effect involves both smooth muscle and endothelial cell pathways.
• Mirabegron warrants further investigation as a potential treatment for preterm labor.